Table 4.

Remission rate of different groups evaluated by combination of serum anti-PLA2R and glomerular PLA2R antigen.

	Remission rate (n, %)
	Serum− & tissue-	Serum− & tissue+	Serum < 150 & tissue−	Serum < 150 & tissue+	Serum ≥ 150 & tissue−	Serum ≥ 150 & tissue+
CR*	5/14	9/33	5/19	9/31	2/4	6/24
	35.7%	27.3%	26.3%	29.0%	50.0%	25.0%
PR + CR	8/14	24/33	13/19	15/31	4/4	14/24
	57.1%	72.7%	68.4%	48.4%	100%	58.3%
NR	6/14	9/33	6/19	16/31	0/4	10/24
	42.9%	27.3%	31.6%	51.6%	0	41.7%

*p < 0.001, Complete remission rates were different among six groups.

CR: complete remission; PR: partial remission; NR: no response.